Thermo Fisher Scientific Human TAB1 Synthetic Peptide
인간 TAB1 중심부 13개 아미노산 서열 기반 합성 펩타이드로, PA5-20084 항체의 블로킹 펩타이드로 사용 가능. TGF-β 및 MAPK 경로 연구용으로 적합하며, 고순도 정제된 액상 형태로 제공. 연구용 한정 제품.
- 카탈로그번호
- PEP0202
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific Human TAB1 Synthetic Peptide
Thermo Fisher Scientific Human TAB1 Synthetic Peptide
Applications
- Control (Ctrl): Assay-dependent
- Blocking Assay (BLOCK): Assay-dependent
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Human |
| Class | Synthetic |
| Type | Peptide |
| Conjugate | Unconjugated |
| Form | Liquid |
| Concentration | 200 µg/mL |
| Purification | Purified |
| Storage Buffer | PBS, pH 7.2, with 0.1% BSA |
| Contains | 0.02% sodium azide |
| Storage Conditions | -20°C |
Product Specific Information
This peptide corresponds to 13 amino acids near the center of human TAB1.
PEP-0202 can be used as a blocking peptide with polyclonal antibody PA5-20084.
Target Information
TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (TAB1) is a regulator of the MAP kinase kinase kinase MAP3K7/TAK1, mediating various intracellular signaling pathways such as those induced by TGF beta, interleukin 1, and WNT-1. TAB1 interacts with and activates TAK1 kinase.
The C-terminal portion of TAB1 is sufficient for binding and activation of TAK1, while the N-terminal portion acts as a dominant-negative inhibitor of TGF beta, suggesting TAB1 functions as a mediator between TGF beta receptors and TAK1.
TAB1 also interacts with and activates MAPK14/p38alpha, representing an alternative activation pathway contributing to MAPK14 biological responses.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기
문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.